Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent Deferred RevenueGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Metlife (MET-PF) Receivables (2016 - 2025)

Metlife has reported Receivables over the past 17 years, most recently at $49.1 billion for Q4 2025.

  • Quarterly results put Receivables at $49.1 billion for Q4 2025, up 64.65% from a year ago — trailing twelve months through Dec 2025 was $49.1 billion (up 64.65% YoY), and the annual figure for FY2025 was $49.1 billion, up 64.65%.
  • Receivables for Q4 2025 was $49.1 billion at Metlife, up from $3.3 billion in the prior quarter.
  • Over the last five years, Receivables for MET-PF hit a ceiling of $49.1 billion in Q4 2025 and a floor of $2.8 billion in Q2 2022.
  • Median Receivables over the past 5 years was $20.9 billion (2021), compared with a mean of $21.7 billion.
  • Biggest five-year swings in Receivables: plummeted 86.87% in 2022 and later surged 661.63% in 2023.
  • Metlife's Receivables stood at $2.9 billion in 2021, then surged by 591.9% to $19.8 billion in 2022, then surged by 59.28% to $31.6 billion in 2023, then fell by 5.51% to $29.8 billion in 2024, then skyrocketed by 64.65% to $49.1 billion in 2025.
  • The last three reported values for Receivables were $49.1 billion (Q4 2025), $3.3 billion (Q3 2025), and $34.5 billion (Q2 2025) per Business Quant data.